ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C07K PEPTIDES 10126
 
  
 
A46B BRUSHES 228
 
  
 
A47K SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR 225
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 2152
 
  
 
G06K RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 2196
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61C DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE 156
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0319,017 APPARATUS FOR CLEANING HUMAN BODY ORIFICEOct 12, 16Nov 09, 17[A46B, A47K]
2017/0258,992 INJECTION PUMP CONTROL METHOD, CONTROL UNIT, AND INJECTION PUMPNov 13, 15Sep 14, 17[A61M]
2017/0007,671 FORMULA OF NEUREGULIN PREPARATIONDec 17, 14Jan 12, 17[A61K]
2016/0324,876 VITAMIN D AND ANTIBACTERIAL USES OF COMPOSITIONS THEREOFDec 25, 14Nov 10, 16[A61K]
2016/0152,727 METHOD FOR INHIBITING CELL GROWTH USING ANTI-ERBB-3 ANTIBODIESNov 24, 15Jun 02, 16[C07K]
2016/0095,903 EXTENDED RELEASE OF NEUREGULIN FOR IMPROVED CARDIAC FUNCTIONDec 10, 15Apr 07, 16[A61K]
2015/0284,440 COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETIC PATIENTSOct 08, 12Oct 08, 15[C07K]
2009/0156,488 USE OF NEUREGULIN FOR ORGAN PRESERVATIONSep 09, 08Jun 18, 09[A61K, A01N, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9788693 Apparatus for cleaning human body orificeOct 12, 16Oct 17, 17[A46B, A47K, A61C]
9783456 Method for inhibiting cell growth using anti-ErbB-3 and anti-ErbB-2 antibodiesJun 16, 00Oct 10, 17[A61K, C03C]
9655949 Neuregulin based methods for treating heart failureJun 22, 15May 23, 17[A61K, H01L, C07K, G06K]
9592339 Syringe pump and drive system thereofNov 21, 12Mar 14, 17[A61M]
9580515 Neukinase, a downstream protein of neuregulinAug 20, 07Feb 28, 17[A61K, C12Q, C12N, G01N, C07K]
9555076 Neuregulin based methods and compositions for treating cardiovascular diseasesMay 06, 14Jan 31, 17[A61K, C07K]
9434777 Neuregulin peptides and their useMar 13, 15Sep 06, 16[A61K, C07K]
9340597 Neuregulin variants and methods of screening and using thereofMar 21, 13May 17, 16[A61K, G01N, C07K]
9089524 Neuregulin based methods for treating heart failureJun 12, 10Jul 28, 15[A61K, H01L, C07K, G06K]
9012400 Neuregulin peptides and their useDec 09, 13Apr 21, 15[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0319,018 APPARATUS FOR CLEANING HUMAN BODY ORIFICEAbandonedOct 12, 16Nov 09, 17[A46B, A47K]
2011/0229,444 Neuregulin And Cardiac Stem CellsAbandonedNov 09, 09Sep 22, 11[A61K, C12N, A61P]
2011/0229,478 ERBB3 BASED METHODS AND COMPOSITIONS FOR TREATING NEOPLASMSAbandonedFeb 25, 11Sep 22, 11[A61K, A61P, C07K]
2007/0213,264 Neuregulin variants and methods of screening and using thereofAbandonedDec 02, 05Sep 13, 07[A61K, G06F, C07K]
2007/0190,127 Extended release of neuregulin for improved cardiac functionAbandonedDec 29, 06Aug 16, 07[A61K]
2007/0129,296 Cardiac muscle function and manipulationAbandonedMay 04, 06Jun 07, 07[A61K]
2006/0199,767 Cardiac muscle function and manipulationAbandonedMay 04, 06Sep 07, 06[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.